In Belgium, Naplasol has acquired mycoprotein company Mycorena and plans to begin producing Mycorena’s mycoprotein, Promyc, at its industrial facility in Bree. The move enables Naplasol to offer a wider range of sustainable solutions for the food, pet food and feed industries. Financial terms of the deal were not disclosed.
Naplasol produces essential proteins via fermentation. It operates production facilities worldwide for the food, pet food and feed industries, and is supported by a global sales network. Mycorena, which is based in Spain, declared bankruptcy last month, citing “significant financial challenges.”
“Both companies, Naplasol and Mycorena, are active in the same field and have complementary knowledge and products of which we can benefit in the future,” Wim Slee, co-CEO of VEOS Group, Naplasol’s parent company, said in a press release. “We are proud that we can continue the story of Mycorena, as we strongly believe in the future of mycoproteins. Mycoproteins are clearly a sustainable protein alternative, with a lower CO2, land and water footprint compared to other plant-based proteins.”
Tags: Belgium, Naplasol
Category: Chemicals & Materials
